We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase III Testing of AstraZeneca COVID-19 Vaccine Candidate Begins

Product News   Sep 04, 2020

 
Phase III Testing of AstraZeneca COVID-19 Vaccine Candidate Begins
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Phase III Trial of Janssen's COVID-19 Vaccine Launched

Product News

Johnson & Johnson today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

READ MORE

IDBS Works With SCIEX To Launch Analyst™ Software Integration

Product News

IDBS announced that it has released a fully-featured integration between the E-WorkBook electronic laboratory notebook (ELN) and SCIEX Analyst® Software, expanding IDBS’s existing family of integrations. This new integration strengthens preclinical capabilities and enables increased regulatory compliance and improved throughput.

READ MORE

PCR Biosystems Launches RiboShield™ RNase Inhibitor

Product News

PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE